The HO-1 effect in cancer cells is not yet clear, but it is widely documented that HO-1 over-expression confers resistance to chemotherapy and radiation therapy due to its reaction products, such as CO or biliverdin/bilirubin [161]. Here, HMOX1 is linked to cancer.